Galera Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates
ROMAN Phase 3 Trial Topline Data Readout Guidance Updated to 2H21 Due to Impact of COVID-19Amendment to Royalty Agreement for […]
BioXcel Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update
Enrollment of the pivotal SERENITY trials is progressing well, with topline data expected in mid-2020The Company is assessing data for […]
TSX News -
Ascot Resources Announces 2020 First Quarter Financial Results
VANCOUVER, British Columbia, May 12, 2020 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) […]
InspireMD Announces First Quarter 2020 Financial Results
First quarter revenue growth driven by continued strong uptake of the CGuard™ Embolic Prevention System (EPS) in the company’s major […]
GasLog Ltd. Announces Delivery of the GasLog Wales and Commencement of 12-Year Charter with JERA
Piraeus, Greece, May 12, 2020 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog” or “the Company”) (NYSE: GLOG) yesterday took delivery of […]
Green Thumb Industries (GTI) to Open Essence South Rainbow, GTI’s Fourth Cannabis Store in the Las Vegas Area and 44th in the Nation, on May 13
CHICAGO and LAS VEGAS, May 12, 2020 (GLOBE NEWSWIRE) — Green Thumb Industries (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading […]
Cabaletta Bio Reports First Quarter 2020 Financial Results and Provides Business Update
PHILADELPHIA, May 12, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery […]
VBL Therapeutics Closes $10.0 Million Registered Direct Offering and Announces $8.1 Million Registered Direct Offering to Key Current Shareholders, Each Priced At-the-Market under Nasdaq Rules
TEL AVIV, Israel, May 12, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), today announced that it has closed the […]
Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. to its Board of Directors
GAITHERSBURG, Md., May 12, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment […]
Karyopharm to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference
NEWTON, Mass., May 12, 2020 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an innovation-driven pharmaceutical company, today announced that Michael […]
